A groundbreaking cancer research project launched in memory of the late Girls Aloud singer Sarah Harding is successfully identifying young women at increased risk of breast cancer after one just year.
On International Nurses Day, Senior Clinical Research Nurses at MFT; Helen and Efstratios share their passion for research and their pride in its transformational role in everyday healthcare practice.
A hormone blood test, developed at MFT can determine the effectiveness of anastrozole, the recommended preventative treatment for post-menopausal women at high risk of developing breast cancer.
For World Antimicrobial Awareness Week, Dr Jan Hansel discusses the importance of therapeutic drug monitoring (TDM) in limiting the development of antimicrobial resistance and the new TDM-TIME study.
In the latest Spotlight On blog, Dr Ahmed discusses the breakthrough STEP HFpEF study and the importance of equality, diversity and inclusivity in research, sharing her first-hand experiences of this.
Good Morning Britain and ITV Granada Reports featured MFT’s BCAN-RAY (Breast Cancer Risk Assessment in Young Women) study, which is running from The Nightingale Centre at Wythenshawe Hospital.
An innovative genetic test that can help prevent newborn babies from going deaf if treated with a common antibiotic, is now being used in routine clinical practice in maternity settings at MFT.